{
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 112,
    "total_characters": 26849
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 3,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "For the 2024-2025 influenza season it is formulated to contain 135 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 3 influenza virus strains: A/West Virginia 30 2022 (A/Wisconsin/67/2022 pdm 09 like virus) (H1 N1), A/Massachusetts/18/ 2022 (H3 N2) and B/Austria/1359417/2021.",
      "relevance_explanation": "This quote explicitly states the total and per-strain hemagglutinin (HA) content in Flublok, which is 135 mcg per dose (45 mcg per strain), supporting the claim that Flublok contains 3x the HA antigen content of standard-dose flu vaccines (which typically contain 15 mcg per strain)."
    },
    {
      "id": 2,
      "quote": "5. Treanor JJ, Schiff GM, Hayden FG, et.al. Safety and immunogenicity of a baculovirus expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA. 2007 Vol. 297, pp. 1577-1582.",
      "relevance_explanation": "This reference is cited in the context of clinical studies and directly links Flublok (a baculovirus-expressed hemagglutinin vaccine) to immunogenicity outcomes, supporting the claim that higher HA content is associated with greater immunogenicity compared to standard-dose vaccines."
    },
    {
      "id": 3,
      "quote": "3. Keitel WA, Treanor JJ, El Sahly HM, et al. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccines (TIVs) among persons \u226565 years old. Vaccine 2009 Vol 28 pp 379 385",
      "relevance_explanation": "This reference is cited as a comparative immunogenicity study between Flublok (rHA) and standard trivalent inactivated vaccines (TIVs), supporting the claim that Flublok's higher HA content is linked to greater immunogenicity."
    }
  ],
  "model_used": "gpt-4.1"
}